Anticorps Recombinant de lapin anti-CEACAM3/6 (CD66c/d)

CEACAM3/6 (CD66c/d) Recombinant Antibody for FC

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain

Applications

FC

Conjugaison

Non conjugué

CloneNo.

241254D1

N° de cat : 98169-1-RR

Synonymes

CD66c, CEACAM3/CD66d, CEACAM6, CEACAM6/CD66c, CEACAM3



Applications testées

Résultats positifs en cytométriehuman peripheral blood leukocytes, FC receptor blocked human peripheral blood leukocytes

Dilution recommandée

ApplicationDilution
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

98169-1-RR cible CEACAM3/6 (CD66c/d) dans les applications de FC et montre une réactivité avec des échantillons Humain

Réactivité Humain
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène Protéine recombinante
Nom complet carcinoembryonic antigen-related cell adhesion molecule 3
Masse moléculaire calculée 252 aa, 27 kDa
Numéro d’acquisition GenBankBC106728
Symbole du gène CEACAM3
Identification du gène (NCBI) 1084
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Protein A purfication
Tampon de stockage PBS with 0.09% sodium azide
Conditions de stockageStore at 2 - 8°C. Stable for one year after shipment.

Informations générales

Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) belong to the immunoglobulin superfamily of cell adhesion molecules. CEACAMs play major roles in cell-cell and cell-ECM adhesion and have been implicated in controlling cell proliferation, angiogenesis, and tissue remodeling (PMID: 23021083). CEACAM3, also named as CD66d and CGM1, is exclusively expressed on granulocytes and acts as the major granulocyte receptor mediating recognition and efficient opsonin-independent phagocytosis of CEACAM-binding microorganisms (PMID: 18606569). CEACAM6, also known as CD66c, is normally expressed on the surface of myeloid and epithelial surfaces and upregulated preferentially at the apical/luminal membranes of many tumors (PMID: 27595061; 35082925). This antibody is raised against 35-155 aa of human CEACAM3/CD66d and can cross-react with CEACAM6/CD66c.

Protocole

Product Specific Protocols
FC protocol for CEACAM3/6 (CD66c/d) antibody 98169-1-RRDownload protocol
Standard Protocols
Click here to view our Standard Protocols
{{ptg:RelatedPrimaryAntibodies}}